National Institute of Hygiene and Epidemiology, Hanoi, Vietnam.
Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.
BMC Infect Dis. 2019 Mar 11;19(1):241. doi: 10.1186/s12879-019-3861-2.
Understanding the relationship between serotype epidemiology and antimicrobial susceptibility of Streptococcus pneumoniae is essential for the effective introduction of pneumococcal conjugate vaccines (PCVs) and control of antimicrobial-resistant pneumococci.
We conducted a community-based study in Nha Trang, central Vietnam, to clarify the serotype distribution and pattern of S. pneumoniae antimicrobial susceptibility in children under 5 years of age and to identify risk factors for carrying antimicrobial-resistant strains. Nasopharyngeal swabs collected from children with acute respiratory infections (ARIs) hospitalized between April 7, 2008, and March 30, 2009, and from healthy children randomly selected in July 2008 were subjected to bacterial culture. Minimum inhibitory concentrations (MICs) against S. pneumoniae were determined, and multiplex-polymerase chain reaction (PCR) serotyping assays were performed. Logistic regression was applied to identify risk factors.
We collected 883 samples from 331 healthy children and 552 ARI cases; S. pneumoniae was isolated from 95 (28.7%) healthy children and 202 (36.6%) ARI cases. Age and daycare attendance were significantly associated with pneumococcal carriage. In total, 18.0, 25.8 and 75.6% of the isolates had high MICs for penicillin (≥4 μg/ml), cefotaxime (≥2 μg/ml) and meropenem (≥0.5 μg/ml), respectively. The presence of pneumococci non-susceptible to multiple beta-lactams was significantly associated with serotype 19F (Odds Ratio: 4.23) and daycare attendance (Odds Ratio: 2.56) but not ARIs, age or prior antimicrobial use. The majority of isolates non-susceptible to multiple beta-lactams (90%) were PCV13 vaccine serotypes.
S. pneumoniae serotype 19F isolates non-susceptible to multiple beta-lactams are widely prevalent among Vietnamese children. Vaccine introduction is expected to significantly increase drug susceptibility.
了解肺炎链球菌血清型流行病学和抗生素敏感性之间的关系对于有效引入肺炎球菌结合疫苗(PCV)和控制抗生素耐药肺炎球菌至关重要。
我们在越南中部芽庄进行了一项社区研究,旨在阐明 5 岁以下儿童中肺炎链球菌血清型分布和抗生素敏感性模式,并确定携带抗生素耐药菌株的危险因素。2008 年 4 月 7 日至 2009 年 3 月 30 日期间因急性呼吸道感染(ARI)住院的儿童和 2008 年 7 月随机选择的健康儿童的鼻咽拭子进行细菌培养。测定肺炎链球菌的最小抑菌浓度(MIC),并进行多重聚合酶链反应(PCR)血清分型检测。应用逻辑回归识别危险因素。
我们从 331 名健康儿童和 552 名 ARI 病例中收集了 883 份样本;从 95 名(28.7%)健康儿童和 202 名(36.6%)ARI 病例中分离出肺炎链球菌。年龄和日托出勤率与肺炎球菌携带显著相关。总共有 18.0%、25.8%和 75.6%的分离株对青霉素(≥4μg/ml)、头孢噻肟(≥2μg/ml)和美罗培南(≥0.5μg/ml)的 MIC 较高。对多种β-内酰胺类药物不敏感的肺炎球菌与血清型 19F(比值比:4.23)和日托出勤率(比值比:2.56)显著相关,但与 ARI、年龄或既往使用抗生素无关。对多种β-内酰胺类药物不敏感的大多数分离株(90%)为 PCV13 疫苗血清型。
对多种β-内酰胺类药物不敏感的血清型 19F 肺炎链球菌分离株在越南儿童中广泛流行。疫苗的引入预计将显著提高药物敏感性。